SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Virendra N. Sehgal, Najeeba Riyaz, Kingshuk Chatterjee, Pradeep Venkatash, Sonal Sharma, Sarcoidosis as a systemic disease, Clinics in Dermatology, 2014, 32, 3, 351

    CrossRef

  2. 2
    Yevgeniy Balagula, Sewon Kang, Manisha J. Patel, Synergism between mTOR pathway and ultraviolet radiation in the pathogenesis of squamous cell carcinoma and its implication for solid-organ transplant recipients, Photodermatology, Photoimmunology & Photomedicine, 2014, 30, 5
  3. 3
    Nir Erdinest, Abraham Solomon, Topical immunomodulators in the management of allergic eye diseases, Current Opinion in Allergy and Clinical Immunology, 2014, 14, 5, 457

    CrossRef

  4. 4
    Neha P. Shah, Rishi M. Goel, Michael Escudier, Treatment of a Crohn's disease–related cutaneous facial lesion with topical tacrolimus, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2014, 118, 3, e71

    CrossRef

  5. 5
    Pallavi V. Pople, Kamalinder K. Singh, Development and evaluation of colloidal modified nanolipid carrier: Application to topical delivery of tacrolimus, Part II – In vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis, European Journal of Pharmaceutics and Biopharmaceutics, 2013, 84, 1, 72

    CrossRef

  6. 6
    Giuseppe Bersani, Pietropaolo Marino, Giuseppe Valeriani, Valentina Cuoco, Claudia Zitelli, Claudia Melcore, Francesco Saverio Bersani, Manic-Like Psychosis Associated with Elevated Trough Tacrolimus Blood Concentrations 17 Years after Kidney Transplant, Case Reports in Psychiatry, 2013, 2013, 1

    CrossRef

  7. 7
    J. Rodrigo Diaz-Siso, Ericka M. Bueno, Geoffroy C. Sisk, Francisco M. Marty, Bohdan Pomahac, Stefan G. Tullius, Vascularized composite tissue allotransplantation – state of the art, Clinical Transplantation, 2013, 27, 3
  8. 8
    Pallavi V. Pople, Kamalinder K. Singh, Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis—Part II: In vivo assessment of dermatopharmacokinetics, biodistribution and efficacy, International Journal of Pharmaceutics, 2012, 434, 1-2, 70

    CrossRef

  9. 9
    Virendra N. Sehgal, Prashant Verma, Sonal Sharma, Govind Srivastava, Ashok K. Aggarwal, Farhan Rasool, Kingsuk Chatterjee, Acrodermatitis continua of Hallopeau: evolution of treatment options, International Journal of Dermatology, 2011, 50, 10
  10. 10
    Virendra N. SEHGAL, Govind SRIVASTAVA, Ashok K. AGGARWAL, Alpna D. SHARMA, Hand dermatitis/eczema: Current management strategy, The Journal of Dermatology, 2010, 37, 7
  11. 11
    VN Sehgal, Role of tacrolimus (FK506) 0.1% ointment WW in vitiligo in children and imperatives of combine therapy with Trioxsalen and Silymarin suspension in progressive vitiligo, Journal of the European Academy of Dermatology and Venereology, 2009, 23, 10
  12. 12
    Josep Manel Casanova, Verónica Sanmartín, Xavier Soria, Marta Ferran, Ramon M. Pujol, Miquel Ribera, Tratamiento tópico de la psoriasis, Piel, 2009, 24, 10, 556

    CrossRef

  13. 13
    Rafael Falabella, Maria I. Barona, Update on skin repigmentation therapies in vitiligo, Pigment Cell & Melanoma Research, 2009, 22, 1